Methotrexate based oral chemotherapy for advanced oral cancer during COVID-19 pandemic: Another option in the therapeutic armamentarium.
作者信息
Kaul Pallvi, Singh Mahendra Pal, Pasricha Rajesh, Garg Pankaj Kumar
机构信息
Department of Surgical Oncology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Department of Radiation Oncology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
出版信息
Oral Oncol. 2020 Aug;107:104839. doi: 10.1016/j.oraloncology.2020.104839. Epub 2020 Jun 4.
Abstract
摘要
相似文献
1
Methotrexate based oral chemotherapy for advanced oral cancer during COVID-19 pandemic: Another option in the therapeutic armamentarium.在新冠疫情期间，基于甲氨蝶呤的口服化疗用于晚期口腔癌：治疗手段中的另一种选择。
Oral Oncol. 2020 Aug;107:104839. doi: 10.1016/j.oraloncology.2020.104839. Epub 2020 Jun 4.
2
Virtual assistance in oral medicine for prioritizing oral cancer diagnosis during the COVID-19 pandemic.在新冠疫情期间，口腔医学中的虚拟辅助用于优先进行口腔癌诊断。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Jul;130(1):127-128. doi: 10.1016/j.oooo.2020.04.009. Epub 2020 Apr 18.
3
Early oral cancer management during the COVID-19 period.COVID-19 期间早期口腔癌的管理
Br J Oral Maxillofac Surg. 2020 Oct;58(8):885-887. doi: 10.1016/j.bjoms.2020.06.043. Epub 2020 Aug 13.
4
Oral cancer and ACE2 receptor of SARS-CoV-2.口腔癌与新型冠状病毒2的血管紧张素转换酶2受体
Oral Oncol. 2020 Sep;108:104920. doi: 10.1016/j.oraloncology.2020.104920. Epub 2020 Jul 21.
5
The Kerala Model of health care delivery and its impact on Oral cancer care during the COVID 19 pandemic.喀拉拉邦的医疗保健提供模式及其对 COVID-19 大流行期间口腔癌护理的影响。
Oral Oncol. 2020 Jul;106:104769. doi: 10.1016/j.oraloncology.2020.104769. Epub 2020 May 3.
6
Continuing education in oral cancer during coronavirus disease 2019 (covid-19) outbreak.2019冠状病毒病（COVID-19）疫情期间口腔癌的继续医学教育
Oral Oncol. 2020 Jun;105:104713. doi: 10.1016/j.oraloncology.2020.104713. Epub 2020 Apr 16.
7
JAK Inhibition with Methotrexate as Treatment for COVID-19 Is a Double-Edged Sword.使用甲氨蝶呤抑制JAK作为治疗新冠病毒病的方法是一把双刃剑。
Int Arch Allergy Immunol. 2020;181(7):563-564. doi: 10.1159/000508750. Epub 2020 May 26.
8
The importance of IL-6 blockade beyond the COVID-19 pandemic: Consideration for cancer care.白细胞介素-6阻断在新冠疫情之外的重要性：对癌症治疗的考量
Radiother Oncol. 2020 Oct;151:24-25. doi: 10.1016/j.radonc.2020.07.018. Epub 2020 Jul 13.
9
Impact of COVID-19 on the early detection of oral cancer: A special emphasis on high risk populations.2019冠状病毒病对口腔癌早期检测的影响：特别关注高危人群。
Oral Oncol. 2020 Jul;106:104760. doi: 10.1016/j.oraloncology.2020.104760. Epub 2020 May 3.
10
Immunotherapy is a preferred option for oral cancer patients during COVID-19 pandemic?在新冠疫情期间，免疫疗法对口腔癌患者来说是首选方案吗？
Oral Oncol. 2020 Aug;107:104860. doi: 10.1016/j.oraloncology.2020.104860. Epub 2020 Jun 15.
引用本文的文献
1
Impact of the COVID-19 pandemic in the head and neck cancer treatment in the Brazil.新冠疫情对巴西头颈癌治疗的影响。
Oral Oncol. 2021 May;116:105148. doi: 10.1016/j.oraloncology.2020.105148. Epub 2021 Jan 18.
本文引用的文献
1
Oral Cancer Surgery and COVID pandemic - Metronomic Therapy shows a promising role while awaiting surgery.口腔癌手术与新冠大流行——在等待手术期间，节拍化疗显示出有前景的作用。
Oral Oncol. 2020 Jul;106:104814. doi: 10.1016/j.oraloncology.2020.104814. Epub 2020 May 22.
2
Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic.2019冠状病毒病大流行期间头颈部癌症患者治疗国际指南的紧急变更。
Oral Oncol. 2020 Aug;107:104734. doi: 10.1016/j.oraloncology.2020.104734. Epub 2020 Apr 24.
3
Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks.COVID-19 大流行期间的头颈部肿瘤学：鉴于新的手术和其他多层次风险，重新考虑传统的治疗模式。
Oral Oncol. 2020 Jun;105:104684. doi: 10.1016/j.oraloncology.2020.104684. Epub 2020 Apr 6.
4
Operable Oral Tongue Squamous Cell Cancer: 15 Years Experience at a Tertiary Care Center in North India.可手术切除的口腔舌鳞状细胞癌：印度北部一家三级医疗中心的15年经验
Indian J Surg Oncol. 2018 Mar;9(1):15-23. doi: 10.1007/s13193-017-0658-x. Epub 2017 May 11.
5
Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial.顺铂和氟尿嘧啶单药或联合多西他赛诱导化疗治疗局部晚期头颈部鳞状细胞癌：TAX 324 随机 3 期试验的长期结果。
Lancet Oncol. 2011 Feb;12(2):153-9. doi: 10.1016/S1470-2045(10)70279-5. Epub 2011 Jan 11.
6
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.顺铂、氟尿嘧啶和多西他赛用于不可切除的头颈癌治疗
N Engl J Med. 2007 Oct 25;357(17):1695-704. doi: 10.1056/NEJMoa071028.
Zotero 插件